|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: OCULAR SCIENCES INC /DE/, 10-Q, 2000-11-14 |
Next: OCULAR SCIENCES INC /DE/, 10-Q, EX-27.01, 2000-11-14 |
<PAGE> 1
OCULAR SCIENCES, INC.
STATEMENT REGARDING COMPUTATION OF NET INCOME PER SHARE (BASIC AND DILUTED)
<TABLE>
<CAPTION>
Three Months Ended Nine Months Ended
September 30, September 30,
----------------------------- -----------------------------
2000 1999 2000 1999
----------- ----------- ----------- -----------
<S> <C> <C> <C> <C>
Net income per share (basic):
Net income $ 7,490,000 $10,424,000 $32,100,000 $26,393,000
=========== =========== =========== ===========
Weighted average common shares outstanding 23,242,364 22,933,623 23,120,459 22,790,938
=========== =========== =========== ===========
Net income per share (basic) $ 0.32 $ 0.45 $ 1.39 $ 1.16
=========== =========== =========== ===========
Net income per share (diluted):
Net income (diluted): $ 7,490,000 $10,424,000 $32,101,000 $26,393,000
=========== =========== =========== ===========
Weighted average common shares outstanding 23,242,364 22,933,623 23,120,459 22,790,938
Weighted average shares of stock options
under the treasury stock method 108,079 420,621 272,771 642,855
----------- ----------- ----------- -----------
Weighted average common and dilutive
potential common shares outstanding 23,350,443 23,354,244 23,393,230 23,433,793
=========== =========== =========== ===========
Net income per share (diluted) $ 0.32 $ 0.45 $ 1.37 $ 1.13
=========== =========== =========== ===========
</TABLE>
29
|
|